Xylometazoline loaded chitosan nanoparticles: fabrication, optimization and evaluation for nasal congestion (Record no. 17328)

MARC details
000 -LEADER
fixed length control field a
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220825151117.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220825b xxu||||| |||| 00| 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency AIKTC-KRRC
Transcribing agency AIKTC-KRRC
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 17598
Author Attri, Kavita
245 ## - TITLE STATEMENT
Title Xylometazoline loaded chitosan nanoparticles: fabrication, optimization and evaluation for nasal congestion
250 ## - EDITION STATEMENT
Volume, Issue number Vol.56(3), Jul-Sep
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Karnataka
Name of publisher, distributor, etc. Association of Pharmaceutical Teachers of India (APTI)
Year 2022
300 ## - PHYSICAL DESCRIPTION
Pagination 716-722p.
520 ## - SUMMARY, ETC.
Summary, etc. Aim: The present study aims at exploring the development of xylometazoline hydrochloride<br/>loaded chitosan nanoparticles (XYL-NP) cross linked with calcium chloride for the<br/>treatment of nasal congestion. Materials and Methods: XYL-NP were prepared using<br/>different polymer like chitosan, cross linking agent calcium chloride and glacial acetic<br/>acid as a solvent enhancer using ionotropic gelation method, which was further optimized<br/>and validated by Box-Behnken Design. Further, these particles were characterised for<br/>size, morphology and evaluated for its release and permeability studies. Results: XYL-NP<br/>showed a particle size of 172+0.4 nm and a PDI of 0.27. The obtained charged<br/>nanoparticles showed encapsulation efficiency of 90.5%. Transmission Electron<br/>Microscopy (TEM) and Scanning Electron Microscopy (SEM) studies showed nanoparticles<br/>have small size and smooth morphology and an<br/>in-vitro drug release of 81.2 %, following<br/>Peppas-korsemeyer release model.96.3% of the drug was permeated through the nasal<br/>mucosa of the goat in a time period of 8 hr. Conclusion: Release and permeation results<br/>shows the capability of the nanoparticles to retain large amount of XYL-NP inside the<br/>mucosa. Hence XYL-NP can be used in treating nasal congestion as the fabricated<br/>formulation has good bioadhesive and mucoadhesive property.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
9 (RLIN) 4639
Topical term or geographic name entry element PHARMACEUTICS
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 17599
Co-Author Singh, Manvi
773 0# - HOST ITEM ENTRY
Place, publisher, and date of publication Bengluru Association of Pharmaceutical Teachers of India (APTI)
Title Indian journal of pharmaceutical education and research
International Standard Serial Number 0019-5464
856 ## - ELECTRONIC LOCATION AND ACCESS
URL https://www.ijper.org/sites/default/files/IndJPhaEdRes-56-3-716.pdf
Link text Click here
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Articles Abstract Database
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
    Dewey Decimal Classification     School of Pharmacy School of Pharmacy Archieval Section 25/08/2022   2022-1378 25/08/2022 25/08/2022 Articles Abstract Database
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.